- Home
- KURA vs BH Comparison
KURA vs BH Comparison
Compare KURA & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | BH |
|---|---|---|
| Founded | 2014 | 1934 |
| Country | United States | United States |
| Employees | N/A | 2359 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.6M | 971.1M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | BH |
|---|---|---|
| Price | $9.54 | $343.73 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.56 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 64.7K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | ★ N/A | $597.67 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $234.92 |
| 52 Week High | $12.49 | $483.60 |
Technical Indicators
Market Signals| Indicator | KURA | BH |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 72.54 |
| Support Level | $8.72 | $299.54 |
| Resistance Level | $9.82 | $362.62 |
| Average True Range (ATR) | 0.51 | 16.55 |
| MACD | -0.04 | 7.17 |
| Stochastic Oscillator | 50.92 | 91.48 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.